Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
GALN On Other Exchanges
Symbol
Exchange
OTC US
SIX Swiss Ex
All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Untermattweg 8

Bern, 3027

Switzerland

Phone: 41 58 852 81 11

Fax: 41 58 852 81 12

Galenica Ltd. engages in the development, manufacture, and distribution of pharmaceutical products in Switzerland and internationally. It operates through two business units, Vifor Pharma and Galenica Santé. The company offers iron replacement products, including Ferinject/Injectafer, Venofer, Maltofer, and Velphoro; immuno-stimulant products, such as Broncho-Vaxom and Uro-Vaxom; infectious diseases/OTX products, over-the-counter products, and herbal remedies; and synthetic and biotech drugs for use in immunology and the treatment of infectious diseases. It also markets products manufactured by third parties; provides products for patients suffering from chronic kidney disease; and develops and markets CellCept for various applications involving auto-immune diseases. In addition, the company offers pre-wholesale logistics services, including storage and distribution of products, and debt collection services to pharmaceutical and healthcare companies; supplies healthcare products to pharmacies, physicians, drug stores, care homes, and hospitals; and handles and coordinates product purchasing, sales, warehousing, and distribution of products for third parties. Further, it operates approximately 318 own pharmacies and 173 partner pharmacies under the Amavita and Sun Store brands in Switzerland; a chain of 61 own pharmacies in partnership under the Coop Vitality brand; MediService specialty pharmacy that offers medication for the treatment of patients in their own homes; and 161 Winconcept partner pharmacies. Additionally, the company provides master data systems for the healthcare market; publishes printed and electronic technical information on pharmaceutical products; maintains databases; offers management solutions under Triamun brand; TriaPharm total management software solution for pharmacies; TriaOne non-sector specific ERP solution for retail; and TriaMed software for physicians. Galenica Ltd. was founded in 1927 and is headquartered in Bern, Switzerland.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALN:SW SFr.0.00 CHF 0.00

GALN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $90.48 USD +0.95
Celesio AG €26.50 EUR -0.038
McKesson Corp $228.52 USD +1.35
UDG Healthcare PLC 531.50 GBp +6.00
Walgreens Boots Alliance Inc $86.08 USD -0.04
View Industry Companies
 

Industry Analysis

GALN

Industry Average

Valuation GALN Industry Range
Price/Earnings 21.2x
Price/Sales 1.7x
Price/Book 3.5x
Price/Cash Flow 16.7x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALENICA AG-REG, please visit www.galenica.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.